GlucoThera

GlucoThera is a glucose-based peritoneal dialysis solution developed by Iperboreal Pharma for the treatment of End-Stage Renal Disease (ESRD). It is designed for intraperitoneal administration in patients undergoing either Continuous Ambulatory Peritoneal Dialysis (CAPD) or Automated Peritoneal Dialysis (APD). The solution functions by utilizing glucose as an osmotic agent to create a concentration gradient across the peritoneal membrane. This gradient facilitates ultrafiltration, the removal of excess fluid from the blood, and the exchange of solutes, allowing metabolic waste products to diffuse from the peritoneal capillaries into the dialysis solution. GlucoThera is part of a broader portfolio of dialysis fluids that includes low-sodium and carnitine-supplemented variants.

Brand names

GlucoThera